Eminence Capital’s ICU Medical ICUI Stock Holding History

Eminence Capital’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-83,220	Closed	-$15.3M	–	84
2020 Q2	$15.3M	Buy	+83,220	New	+$16.5M	0.15%	72

Other funds holding ICUI

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FPP

Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return

Nitorum Capital New York $114M AUM 17.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Eminence Capital's ICUI Position: Q3 2020 in Review

Eminence Capital sold out of ICU Medical (ICUI) in Q3 2020, closing a stake of 83,220 shares — an estimated $15.3M sold.

Eminence Capital first reported a position in ICUI in Q2 2020 and held it in 1 quarter. The position peaked at $15.3M in Q2 2020. 283 funds tracked by Wall St. Rank hold ICUI as of Q3 2020.

Eminence Capital reported no remaining ICU Medical position as of Q3 2020 after selling out during the quarter.
Eminence Capital sold 83,220 ICU Medical shares in Q3 2020, an estimated $15.3M.
Eminence Capital first reported a position in ICU Medical in Q2 2020 and held it in 1 quarter.
Eminence Capital's ICU Medical position peaked at $15.3M in Q2 2020.
283 funds tracked by Wall St. Rank held ICU Medical as of Q3 2020.

Based on Eminence Capital's 13F filing for Q3 2020, filed 16 Nov 2020.